APA (7th ed.) Citation

Gennaro De Pascale, Gabriele Pintaudi, Lucia Lisi, Flavio De Maio, Salvatore Lucio Cutuli, Eloisa Sofia Tanzarella, . . . Massimo Antonelli. (2023). Use of High-Dose Nebulized Colistimethate in Patients with Colistin-Only Susceptible <i>Acinetobacter baumannii</i> VAP: Clinical, Pharmacokinetic and Microbiome Features. MDPI AG.

Chicago Style (17th ed.) Citation

Gennaro De Pascale, et al. Use of High-Dose Nebulized Colistimethate in Patients with Colistin-Only Susceptible <i>Acinetobacter Baumannii</i> VAP: Clinical, Pharmacokinetic and Microbiome Features. MDPI AG, 2023.

MLA (9th ed.) Citation

Gennaro De Pascale, et al. Use of High-Dose Nebulized Colistimethate in Patients with Colistin-Only Susceptible <i>Acinetobacter Baumannii</i> VAP: Clinical, Pharmacokinetic and Microbiome Features. MDPI AG, 2023.